Protect Pharmaceutical 

$0.075000
6
-$0.05-42.31%Monday 18:25

Statistics

Day High
0.075
Day Low
0.07
52W High
0.479
52W Low
0.02
Volume
44,963
Avg. Volume
11,917
Mkt Cap
4.31M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Jun 30Expected
Q3 2016
Q4 2016
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
-0.09
-0.06
-0.03
-0
Expected EPS
N/A
Actual EPS
-0.004

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-332.69MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a global pharmaceutical company that competes with Protect Pharmaceutical in various therapeutic areas, including vaccines and advanced biopharmaceuticals.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is a leading healthcare company that offers innovative health solutions and directly competes in the pharmaceutical and biotech sectors.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a diversified healthcare giant that competes across multiple segments, including pharmaceuticals, with a broad range of products.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie operates in similar therapeutic areas as Protect Pharmaceutical, focusing on immunology, oncology, and virology, making it a direct competitor.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences specializes in antiviral drugs for HIV, hepatitis B, hepatitis C, and influenza, competing in the pharmaceutical sector with innovative therapies.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biopharmaceutical company that competes with Protect Pharmaceutical in areas like oncology, cardiovascular disease, and bone health.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is a global biopharmaceutical company that competes in the development of prescription pharmaceuticals in several therapeutic areas.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that competes with Protect Pharmaceutical through its diversified portfolio in pharmaceuticals, eye care, and generics.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare, competing with a focus on pharmaceuticals and diagnostics in oncology, immunology, and infectious diseases.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company competing in areas like cardiovascular, renal, metabolism, and respiratory diseases.

About

Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name to Protect Pharmaceutical Corporation in March 2010. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada.
Show More
CEO
Boris Stepanov
Employees
600
Country
United States
ISIN
US74364W2035

Listings

0 Comments

Share your thoughts

FAQs

What is Protect Pharmaceutical stock price today?▼
The current price of PRTT is $0.08 USD — it has decreased by -42.31% in the past 24 hours. Watch Protect Pharmaceutical stock price performance more closely on the chart.
What is Protect Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Protect Pharmaceutical stocks are traded under the ticker PRTT.
Is Protect Pharmaceutical stock price growing?▼
PRTT stock has fallen by -42.31% compared to the previous week, the month change is a -55.88% fall, over the last year Protect Pharmaceutical has showed a -54.55% decrease.
What is Protect Pharmaceutical market cap?▼
Today Protect Pharmaceutical has the market capitalization of 4.31M
What were Protect Pharmaceutical earnings last quarter?▼
PRTT earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Protect Pharmaceutical revenue for the last year?▼
Protect Pharmaceutical revenue for the last year amounts to 0 USD.
What is Protect Pharmaceutical net income for the last year?▼
PRTT net income for the last year is -332.69M USD.
How many employees does Protect Pharmaceutical have?▼
As of November 1, 2026, the company has 600 employees.
In which sector is Protect Pharmaceutical located?▼
Protect Pharmaceutical operates in the Manufacturing sector.
When did Protect Pharmaceutical complete a stock split?▼
The last stock split for Protect Pharmaceutical was on November 4, 2014 with a ratio of 1:1000.
Where is Protect Pharmaceutical headquartered?▼
Protect Pharmaceutical is headquartered in Las Vegas, United States.